Celgene and Acceleration Pharma Announce Submission of Luspatercept Biologics License Application to FDA Biotech Investing
Endo Begins Shipment of Authorized Generic Version of PROVENTIL HFA Inhalation Aerosol in the US Pharmaceutical Investing
Tabula Rasa HealthCare’s DoseMe Executes First-ever integration of its Precision Dosing Software with market-leading Electronic Medical Record provider Medical Device Investing
Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project Cannabis Investing News
SELLAS Life Sciences Group and Cancer Center to Study Galinpepimut-S in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma Pharmaceutical Investing
Aptinyx Releases Positive Data on Novel NMDA Receptor Modular Treating Parkinson’s Disease Biotech Investing
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer Biotech Investing
BELLUS Health Receives Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients Biotech Investing
